SearcharxivSearch

arXiv subjects

Kihyun Han

Publications and source records attributed to Kihyun Han.

2 recordsLinked to original sources

PRESCCO: Efficient Prediction Intervals under a Right-Censored Covariate

In clinical studies, a patient's outcome, e.g., a cognitive test score, is typical or atypical depending on how it compares with the outcomes of patients at a similar point in a neurodegenerative disease, measured by how far they are from a common disease event. A prediction interval based on the time to that event provides that comparison, but that time is right-censored for most patients. Yet no method had computed such a prediction interval in this right-censored covariate setting. We first adapt three conformal prediction methods to this setting, and show that the estimated half-length, the distance the interval runs either side of its center, varies from one study to the next, so the same outcome can be judged typical in one study and atypical in another. We then develop the PRESCCO method, whose estimator of the half-length is semiparametrically efficient and doubly robust, staying consistent when one of its two models is misspecified, while the method loses no coverage. In simulations its standard deviation is four to thirty times smaller than under any conformal prediction method, and in a Huntington disease study with 77.2% right-censoring, an outcome typical in one study is no longer atypical in another.

stat.ME

SPYCE: A Doubly Robust Estimator for Trials Targeting Early Huntington Disease under Outcome-Dependent Censoring

Clinical trials for neurodegenerative diseases must identify sensitive endpoints -- outcomes that change rapidly enough to detect treatment effects. In Huntington disease, this requires measuring how outcomes change as participants approach Stage 1. Yet many participants exit studies before reaching this stage, making their time to Stage 1 right-censored. Estimating how outcomes change requires models for both time to Stage 1 and time to study exit. When participants with worse outcomes exit earlier, this outcome-dependent censoring causes existing estimators to produce contradictory results: for the same cognitive outcome, one estimator suggests improvement while another shows decline. Existing estimators either ignore outcome-dependent censoring or require one model to be correctly specified, with no protection when it is not. We introduce SPYCE, a doubly robust estimator (consistent when either model is correctly specified) that achieves the smallest possible variance and allows both models to be estimated nonparametrically without sacrificing efficiency. Applied to data from PREDICT-HD, an observational Huntington disease study, SPYCE resolves current contradictions, identifies caudate and putamen volume ratios as the most promising sensitive endpoints, and shows that as few as 241 participants per arm are needed to detect treatment effects, versus hundreds of thousands under estimators that cannot handle outcome-dependent censoring.

stat.ME